1-3 of 3
C. Cruz, MD
Close
Sort by
Journal Articles

Results of a Clinical Study of Pevonedistat (Pev), a First-in-Class NEDD8-Activating Enzyme (NAE) Inhibitor, Combined with Azacitidine (Aza) in Older Patients (Pts) with Acute Myeloid Leukemia (AML)

Ronan T Swords, MD PhD FRCPI, FRCPath, Steven Coutre, MD, Michael B. Maris, MD, Joshua F. Zeidner, MD, James M. Foran, MD, Jose C. Cruz, MD, Harry P. Erba, MD PhD, Jesus G. Berdeja, MD, Wayne Tam, MD PhD, Saran Vardhanabhuti, PhD, Iwona Dobler, PhD, Hélène M. Faessel, PhD, Ajeeta B. Dash, PhD, Farhad Sedarati, PhD, Bruce J. Dezube, MD, Michael R. Savona, MD
Journal: Blood
Blood (2016) 128 (22): 98.
https://doi.org/10.1182/blood.V128.22.98.98
Published: 2016
Journal Articles

Outcomes of Autologous Transplants for Patients with Multiple Myeloma and Concurrent Multiple Plasmacytomas

Seema Naik, MD, Paul J. Shaughnessy, MD, Behyar Zoghi, MDPhD, Jose C Cruz, MD, Carlos Bachier, MD
Journal: Blood
Blood (2015) 126 (23): 1973.
https://doi.org/10.1182/blood.V126.23.1973.1973
Published: 2015
Journal Articles

Heart Failure Improvement after Autologous Bone Marrow Mononuclear Cells (ABMMC) Transplantation.

Antonio A. Carrasco-Yalan, MD, Roberto Fernandez-Viña, MD, Jorge Castillo-Aguirre, MD, Hugo Rios, MD, Marco Alvarez, TM, R. de Moura, MD, C. Cruz, MD, A. Carrillo, MD, S. Chirinos, TM, E. Ercilla, MD, A. Patel, MD, Jorge Tumak-Mubarak, MD
Journal: Blood
Blood (2007) 110 (11): 3691.
https://doi.org/10.1182/blood.V110.11.3691.3691
Published: 2007